http://topics.cnn.com/topics/feeds/rss/Schering_Plough_CorporationFind stories, videos, and photos about Schering-Plough Corporation from CNN.com.en-usCable News Network LP, LLLP.Thu, 26 Nov 2009 03:54:56 GMT5http://i.cdn.turner.com/cnn/.element/img/1.0/logo/cnn.logo.rss.gifhttp://topics.cnn.com/topics/feeds/rss/Schering_Plough_Corporation14433Find stories, videos, and photos about Schering-Plough Corporation from CNN.com.http://money.cnn.com/2009/04/21/markets/markets_newyork/index.htmhttp://money.cnn.com/2009/04/21/markets/markets_newyork/index.htmStocks gained Tuesday, rebounding after the previous session's rally as worries about corporate results were countered by renewed hopes that the financial sector is closer to stabilizing.Tue, 21 Apr 2009 21:48:00 EDThttp://money.cnn.com/2009/03/11/news/companies/pharma.fortune/index.htmhttp://money.cnn.com/2009/03/11/news/companies/pharma.fortune/index.htmWhen Merck's $41 billion acquisition of Schering-Plough was announced Monday, it confirmed a major trend toward consolidation in Big Pharma.Thu, 12 Mar 2009 16:25:00 EDThttp://money.cnn.com/2009/03/09/markets/markets_newyork/index.htmhttp://money.cnn.com/2009/03/09/markets/markets_newyork/index.htmStocks tumbled Monday, with the Dow and S&P 500 ending at fresh 12-year lows, as Merck's $41 billion purchase of Schering-Plough failed to distract investors from worries about the economy.Mon, 09 Mar 2009 22:18:00 EDThttp://money.cnn.com/2009/03/09/news/companies/merck_schering_plough/index.htmhttp://money.cnn.com/2009/03/09/news/companies/merck_schering_plough/index.htmDrugmaker Merck & Co. announced Monday that it has agreed to acquire rival Schering-Plough Corp. in a deal worth $41.1 billion.Mon, 09 Mar 2009 16:47:00 EDThttp://money.cnn.com/2009/03/09/markets/stockswatch/index.htmhttp://money.cnn.com/2009/03/09/markets/stockswatch/index.htmStocks turned higher Monday morning as investors considered Merck's $41 billion purchase of Schering-Plough and opted to scoop up shares hit in the recent selloff.Mon, 09 Mar 2009 14:22:00 EDThttp://money.cnn.com/2009/02/03/markets/markets_newyork/index.htmhttp://money.cnn.com/2009/02/03/markets/markets_newyork/index.htmStocks rallied Tuesday, erasing morning losses, as investors focused on the day's positive earnings reports and a surprise rise in a key measure of home sales.Tue, 03 Feb 2009 22:57:00 ESThttp://money.cnn.com/2008/08/01/markets/stockswatch/index.htmhttp://money.cnn.com/2008/08/01/markets/stockswatch/index.htmU.S. stock futures rebounded Friday following a better-than-expected July employment report and even as General Motors booked a nearly $16 billion loss.Fri, 01 Aug 2008 12:52:00 EDThttp://money.cnn.com/2008/07/21/markets/markets_newyork/index.htmhttp://money.cnn.com/2008/07/21/markets/markets_newyork/index.htmStocks closed modestly lower Monday, as rising oil prices and concerns in the tech and drug sectors overpowered a better-than-expected earnings report from Bank of America.Mon, 21 Jul 2008 21:53:00 EDThttp://money.cnn.com/2008/07/21/markets/stockswatch/index.htmhttp://money.cnn.com/2008/07/21/markets/stockswatch/index.htmStock futures climbed Monday morning as investors cheered better-than-expected earnings from Bank of America and the announcement of a deal between Yahoo and activist investor Carl Icahn.Mon, 21 Jul 2008 12:26:00 EDThttp://money.cnn.com/2008/04/03/markets/markets_newyork/index.htmhttp://money.cnn.com/2008/04/03/markets/markets_newyork/index.htmStocks inched higher Thursday, as investors continued to bet that the worst of the credit crisis is behind the market. However, gains were limited by some jitters ahead of Friday's big monthly jobs report.Thu, 03 Apr 2008 21:50:00 EDThttp://money.cnn.com/2008/03/31/markets/markets_newyork/index.htmhttp://money.cnn.com/2008/03/31/markets/markets_newyork/index.htmFalling oil prices helped lift stocks Monday, at the end of an otherwise abysmal quarter on Wall Street, marred by fears of a recession amid the housing crisis and credit market fallout.Mon, 31 Mar 2008 21:55:00 EDThttp://money.cnn.com/2008/03/04/news/companies/pharma_votes/index.htmhttp://money.cnn.com/2008/03/04/news/companies/pharma_votes/index.htmDemocrats have long served as the traditional enemy of Big Pharma, but in this presidential campaign, the left is taking the lion's share of drugmaker money.Fri, 07 Mar 2008 19:40:00 ESThttp://money.cnn.com/2008/02/04/technology/simons_cholesterol.fortune/index.htmhttp://money.cnn.com/2008/02/04/technology/simons_cholesterol.fortune/index.htmIs low cholesterol the pathway to a healthier heart? That's certainly what most medical experts - and their patients - have assumed for the last 30 years or so. But a recently-released study of Merck and Schering-Plough's cholesterol-lowering drug, Vytorin, is giving new voice to medical critics who have groused for decades about the questionable benefit of using medications to lower cholesterol and thereby prevent heart disease.Wed, 06 Feb 2008 21:46:00 ESThttp://money.cnn.com/2007/10/22/markets/markets_0130/index.htmhttp://money.cnn.com/2007/10/22/markets/markets_0130/index.htmTechnology shares bounced Monday, helping the broader market erase losses, as investors tiptoed back into stocks after last week's big selloff.Mon, 22 Oct 2007 18:04:00 EDThttp://money.cnn.com/2007/10/22/markets/markets_nyopen/index.htmhttp://money.cnn.com/2007/10/22/markets/markets_nyopen/index.htmU.S. stocks slipped at the start of trading Monday amid continuing concerns about the economy, corporate earnings and the price of oil.Mon, 22 Oct 2007 13:32:00 EDThttp://money.cnn.com/2007/08/31/news/companies/sec_letters/index.htmhttp://money.cnn.com/2007/08/31/news/companies/sec_letters/index.htmThe Securities and Exchange Commission has asked the top brass of nearly 300 U.S. companies to better explain the pay packages of top executives, according to a report Friday.Fri, 31 Aug 2007 12:12:00 EDThttp://money.cnn.com/2007/08/31/magazines/fortune/simons_pharmajv.fortune/index.htmhttp://money.cnn.com/2007/08/31/magazines/fortune/simons_pharmajv.fortune/index.htmSharing is not something most scientists do well. It makes sense. In the laboratory, valuable intellectual property flows from each new discovery. It's the coin of the realm, and as such researchers guard it closely.Fri, 31 Aug 2007 02:50:00 EDThttp://money.cnn.com/2007/07/23/news/companies/bc.scheringplough.results.reut/index.htmhttp://money.cnn.com/2007/07/23/news/companies/bc.scheringplough.results.reut/index.htmSchering-Plough Corp. said Monday that second-quarter earnings rose sharply, fueled by growing demand for its Zetia and Vytorin cholesterol drugs and treatments for arthritis and allergies.Mon, 23 Jul 2007 01:50:00 EDThttp://money.cnn.com/2007/07/23/markets/markets_945/index.htmhttp://money.cnn.com/2007/07/23/markets/markets_945/index.htmStocks got off to a higher start Monday, helped by some surprisingly strong earnings from Dow component Merck and some dealmaking activity.Mon, 23 Jul 2007 01:48:00 EDThttp://money.cnn.com/2007/06/11/pf/bull_market.moneymag/index.htmhttp://money.cnn.com/2007/06/11/pf/bull_market.moneymag/index.htmAre you scared yet? After enjoying records for the Dow and the S&P throughout the spring, investors have faced some rough selloffs in June.Mon, 11 Jun 2007 13:43:00 EDThttp://money.cnn.com/2007/04/25/smbusiness/wharton_competition/index.htmhttp://money.cnn.com/2007/04/25/smbusiness/wharton_competition/index.htmA cure for lower back pain could be the next big business idea - at least that's what a panel of judges thought when they picked the winner of the University of Pennsylvania Wharton School's business plan competition Tuesday.Wed, 25 Apr 2007 15:31:00 EDThttp://money.cnn.com/2007/04/19/markets/movers/index.htmhttp://money.cnn.com/2007/04/19/markets/movers/index.htmThe following are some of Thursday's most actively traded stocks:Thu, 19 Apr 2007 16:46:00 EDThttp://money.cnn.com/2007/04/02/news/companies/drug_rep/index.htmhttp://money.cnn.com/2007/04/02/news/companies/drug_rep/index.htmIt's hard out there for drug sales reps--particularly if they work in places where gaining access to doctors is becoming increasingly difficult.Mon, 02 Apr 2007 19:33:00 EDThttp://money.cnn.com/2007/03/21/news/companies/drug_patents/index.htmhttp://money.cnn.com/2007/03/21/news/companies/drug_patents/index.htmAs Big Pharma faces patent expirations on some of its most lucrative drugs, the industry is trying to reinvigorate sales by finding creative ways to land new patents - but on the same old drugs.Wed, 21 Mar 2007 16:02:00 EDThttp://money.cnn.com/2007/03/16/markets/movers/index.htmhttp://money.cnn.com/2007/03/16/markets/movers/index.htmThe following shares were among the most actively traded Friday:Fri, 16 Mar 2007 14:25:00 EDThttp://money.cnn.com/2007/03/12/markets/movers/index.htmhttp://money.cnn.com/2007/03/12/markets/movers/index.htmThe following shares were among the most actively traded Monday:Mon, 12 Mar 2007 14:41:00 EDThttp://money.cnn.com/2007/03/12/markets/markets_1045/index.htmhttp://money.cnn.com/2007/03/12/markets/markets_1045/index.htmStocks struggled for direction Monday morning as investors weighed a rash of merger and acquisition news with the latest worries about the subprime mortgage lenders.Mon, 12 Mar 2007 14:19:00 EDThttp://money.cnn.com/2007/03/12/markets/markets_0945/index.htmhttp://money.cnn.com/2007/03/12/markets/markets_0945/index.htmStocks were choppy Monday morning as lower oil prices and some merger news vied with ongoing worries about the subprime mortgage lenders and some investor reluctance after last week's advance.Mon, 12 Mar 2007 13:31:00 EDThttp://money.cnn.com/2007/03/12/markets/markets_nyopen/index.htmhttp://money.cnn.com/2007/03/12/markets/markets_nyopen/index.htmU.S. stocks were little changed at Monday's open as concerns about the financial sector in the wake of the latest New Century news overshadowed a slew of deals.Mon, 12 Mar 2007 13:24:00 EDThttp://money.cnn.com/2007/01/03/news/international/update_alk.abello.dj/index.htmhttp://money.cnn.com/2007/01/03/news/international/update_alk.abello.dj/index.htmSTOCKHOLM -(Dow Jones)- Danish vaccine manufacturer ALK-Abello A/S (ALK-B.KO) said Wednesday it has signed a deal with Schering-Plough Corp. (SGP) of the U.S. to develop its tablet-based allergy vaccines for North America, sending shares up as much as 17% in early trading.Wed, 03 Jan 2007 15:01:00 ESThttp://money.cnn.com/2007/01/03/news/companies/bigpharma2007/index.htmhttp://money.cnn.com/2007/01/03/news/companies/bigpharma2007/index.htmNovartis could be the hottest drug giant in 2007, analysts say, with Schering-Plough and Eli Lilly & Co. not far behind.Wed, 03 Jan 2007 13:57:00 ESThttp://money.cnn.com/2006/10/19/news/companies/schering_plough.fortune/index.htmhttp://money.cnn.com/2006/10/19/news/companies/schering_plough.fortune/index.htmCarrie Cox, the 49-year-old EVP; President, Global Pharmaceuticals of Schering-Plough, ranks No. 39 on Fortune's 2006 list of 50 Most Powerful Women.Thu, 19 Oct 2006 16:32:00 EDThttp://money.cnn.com/2006/09/15/news/companies/bristol_schering/index.htmhttp://money.cnn.com/2006/09/15/news/companies/bristol_schering/index.htmThe drug giant Schering-Plough is seriously considering approaching Bristol-Myers with a merger offer, according to a news report.Fri, 15 Sep 2006 12:04:00 EDThttp://money.cnn.com/2006/08/29/news/companies/schering/index.htmhttp://money.cnn.com/2006/08/29/news/companies/schering/index.htmSchering-Plough said Tuesday it settled a criminal investigation into its sales practices and agreed to pay $435 million in fines and damages.Tue, 29 Aug 2006 15:03:00 EDThttp://money.cnn.com/2006/08/08/news/companies/scheringplough/index.htmhttp://money.cnn.com/2006/08/08/news/companies/scheringplough/index.htmDrugmaker Schering-Plough may have wowed investors with strong second-quarter earnings - but the company has a cholesterol problem.Tue, 08 Aug 2006 13:46:00 EDThttp://money.cnn.com/2006/07/24/markets/markets_nyopen/index.htmhttp://money.cnn.com/2006/07/24/markets/markets_nyopen/index.htmStocks jumped at the open Monday, with a pair of big mergers and a pullback in oil prices inspiring investors to scoop up beaten-down shares after last week's pummeling.Mon, 24 Jul 2006 13:16:00 EDThttp://money.cnn.com/2006/07/12/news/companies/drugindustry/index.htmhttp://money.cnn.com/2006/07/12/news/companies/drugindustry/index.htmBig Pharma is feeling the squeeze as name-brand drugs go off patent, which is why analysts are expecting a flat or modest second quarter for most of the biggest U.S. drug makers.Wed, 12 Jul 2006 14:24:00 EDThttp://money.cnn.com/2006/06/26/news/companies/court_rulings/index.htmhttp://money.cnn.com/2006/06/26/news/companies/court_rulings/index.htmThe Supreme Court Monday agreed to consider an appeal by the largest U.S. telephone carriers seeking the dismissal of a class-action antitrust suit against them.Mon, 26 Jun 2006 14:08:00 EDThttp://money.cnn.com/2006/06/20/news/companies/sepracor/index.htmhttp://money.cnn.com/2006/06/20/news/companies/sepracor/index.htmPfizer and Schering-Plough could easily snap up the smaller drugmaker Sepracor but industry analysts say risks to its two products would limit any potential gains.Tue, 20 Jun 2006 18:09:00 EDThttp://money.cnn.com/2006/06/19/news/companies/vytorin/index.htmhttp://money.cnn.com/2006/06/19/news/companies/vytorin/index.htmMerck and Schering-Plough announced a study on Sunday showing that their combination drug Vytorin is better at lowering cholesterol than competing drug Crestor from AstraZeneca.Mon, 19 Jun 2006 10:00:00 EDThttp://money.cnn.com/2006/05/12/news/companies/allergy/index.htmhttp://money.cnn.com/2006/05/12/news/companies/allergy/index.htmAllergy season is in full swing and, in the $25 billion market for respiratory drugs, GlaxoSmithKline is likely to hold its throne as the asthma king for this season and years to come, despite growing competition.Fri, 12 May 2006 19:09:00 EDThttp://money.cnn.com/2006/05/02/news/companies/drug_earnings/index.htmhttp://money.cnn.com/2006/05/02/news/companies/drug_earnings/index.htmNow that the nation's big drugmakers have reported mostly strong first-quarter results, how do things look going forward?Tue, 02 May 2006 10:06:00 EDThttp://money.cnn.com/2006/04/27/news/companies/scheringplough_f500_fortune/index.htmhttp://money.cnn.com/2006/04/27/news/companies/scheringplough_f500_fortune/index.htmSchering-Plough ranks no. 250 on this year's list of the FORTUNE 500, with $9,508 million in revenues, up 14.9% from the previous year. The Kenilworth, N.J.-based company was ranked no. 264 on the 2005 list. Its 2005 profits were $269 million.Thu, 27 Apr 2006 17:37:00 EDThttp://money.cnn.com/2006/04/20/news/companies/drug_earnings/index.htmhttp://money.cnn.com/2006/04/20/news/companies/drug_earnings/index.htmBig drugmakers put up mostly strong earnings this week, triggering a variety of reactions on the stock market and a mixed bag of analyst expectations for the year.Thu, 20 Apr 2006 20:35:00 EDThttp://money.cnn.com/2006/03/15/news/companies/vytorin/index.htmhttp://money.cnn.com/2006/03/15/news/companies/vytorin/index.htmSchering-Plough, once the troubled child of the drug industry, is making a comeback with a hot new drug.Wed, 15 Mar 2006 15:12:00 ESThttp://money.cnn.com/2005/10/24/markets/markets_nyopen/index.htmhttp://money.cnn.com/2005/10/24/markets/markets_nyopen/index.htmFalling oil prices and strong earnings from the drugmaker were among the factors boosting stocks Monday morning.Mon, 24 Oct 2005 13:25:00 EDThttp://money.cnn.com/2005/09/12/news/economy/family_companies/index.htmhttp://money.cnn.com/2005/09/12/news/economy/family_companies/index.htmThree drugmakers are among the companies named to an annual list of the top 10 family-friendly employers unveiled Monday.Mon, 12 Sep 2005 14:54:00 EDThttp://money.cnn.com/2005/07/19/news/fortune500/drugearnings/index.htmhttp://money.cnn.com/2005/07/19/news/fortune500/drugearnings/index.htmIf you're hoping for some good results from the drug sector this week, take an aspirin. With two exceptions, the Street expects the earnings pain among drug makers to continue.Tue, 19 Jul 2005 13:33:00 EDThttp://money.cnn.com/2005/05/11/news/fortune500/generic/index.htmhttp://money.cnn.com/2005/05/11/news/fortune500/generic/index.htmDrugmakers rue the day when patents expire on blockbuster products, but some companies have found ways to relieve the pain of patent loss and wring more sales out of name brands.Wed, 11 May 2005 20:18:00 EDThttp://money.cnn.com/2005/04/25/news/fortune500/coldmedicine/index.htmhttp://money.cnn.com/2005/04/25/news/fortune500/coldmedicine/index.htmAlbertson's Inc., the food and drug retailer, announced Monday that certain over-the-counter cold medicines will now be sold from behind the pharmacy counter, because the key ingredient is used to manufacture illegal drugs.Mon, 25 Apr 2005 12:57:00 EDThttp://money.cnn.com/2005/03/23/news/fortune500/peta_secwin/index.htmhttp://money.cnn.com/2005/03/23/news/fortune500/peta_secwin/index.htmPeople for the Ethical Treatment of Animals (PETA), citing recent Securities and Exchange Commission rulings, said Wednesday that the boards of General Electric and two other companies must allow shareholders to vote on resolutions seeking to replace "painful and deadly" animal testing with more humane alternatives.Wed, 23 Mar 2005 13:03:00 ESThttp://money.cnn.com/2004/02/05/markets/afterbell/index.htmhttp://money.cnn.com/2004/02/05/markets/afterbell/index.htmThe earnings parade continued after the closing bell Thursday as Electronic Data Systems, John Hancock and Maxim Integrated Products all reported quarterly results.Thu, 05 Feb 2004 22:25:00 ESThttp://money.cnn.com/2004/01/29/markets/pharmastocks/index.htmhttp://money.cnn.com/2004/01/29/markets/pharmastocks/index.htmAre the "big pharmas" finally ready to move up from the back of the pack?Thu, 29 Jan 2004 15:24:00 ESThttp://money.cnn.com/2004/01/26/markets/markets_nyopen/index.htmhttp://money.cnn.com/2004/01/26/markets/markets_nyopen/index.htmU.S. stocks were mixed early Monday as investors geared up for quarterly earnings reports from roughly 30 percent of the Standard & Poor's 500 due this week.Mon, 26 Jan 2004 14:13:00 ESThttp://money.cnn.com/2004/01/26/markets/stockswatch/index.htmhttp://money.cnn.com/2004/01/26/markets/stockswatch/index.htmU.S. stocks, fresh off their first losing week of 2004, will be subject to more corporate quarterly results and the December existing home sales figures as the investing week starts Monday.Mon, 26 Jan 2004 10:31:00 ESThttp://money.cnn.com/2003/11/06/magazines/moneymag/mag_isaly_0311/index.htmhttp://money.cnn.com/2003/11/06/magazines/moneymag/mag_isaly_0311/index.htmIn an industry characterized by change, Samuel Isaly has been a rare constant.Thu, 06 Nov 2003 22:29:00 ESThttp://money.cnn.com/magazines/moneymag/moneymag_archive/2003/11/01/352322/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/2003/11/01/352322/index.htmIn an industry characterized by change, Samuel Isaly has been a rare constant. Since becoming a drug analyst at age 23, after graduating from the London School of Economics, the manager of the $2 ...Sat, 01 Nov 2003 05:01:00 ESThttp://money.cnn.com/magazines/fortune/fortune_archive/2002/10/14/330051/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/2002/10/14/330051/index.htmSpringtime on the plains of Midland, Texas, is an asthmatic's nightmare. Along with the tumbleweed and dust, there's always too much pollen floating in the wind. Alexis Milmine feels a stirring in ...Mon, 14 Oct 2002 04:01:00 EDThttp://money.cnn.com/magazines/moneymag/moneymag_archive/2002/08/01/326262/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/2002/08/01/326262/index.htmTALK ABOUT A HIDDEN GEM. Pelican's managers don't court media attention. But this small fund (only $117 million in assets) has been quietly beating the pants off the competition for the past 10 yea...Thu, 01 Aug 2002 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/2000/04/17/278075/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/2000/04/17/278075/index.htmEven through stock market jolts, the merger-and-acquisition frenzy continues unabated. As CEOs struggle to keep pace with changing technology, it gets harder to predict what they'll do. Previously ...Mon, 17 Apr 2000 04:01:00 EDThttp://money.cnn.com/magazines/moneymag/moneymag_archive/1999/10/01/266501/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/1999/10/01/266501/index.htmSTOCKS Bunzl (distributor of packaging material), Iberdrola (Spanish utility), Yalplay (Internet music company), Schering-Plough, Tachihi Enterprise (Japanese real estate manager), Vivendi (French ...Fri, 01 Oct 1999 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/1999/04/26/258785/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1999/04/26/258785/index.htmSize of revenues is the measure we use to rank the FORTUNE 500, but it's not the only one that counts. That's why we also rate the 500 on 12 other performance criteria. Spinoffs and mergers account...Mon, 26 Apr 1999 04:01:00 EDThttp://money.cnn.com/magazines/moneymag/moneymag_archive/1999/02/01/254567/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/1999/02/01/254567/index.htmSTOCKS Mon, 01 Feb 1999 05:01:00 ESThttp://money.cnn.com/magazines/fortune/fortune_archive/1998/08/03/246315/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1998/08/03/246315/index.htmHow does A.G. Edwards outdistance the S&P 500--and many bigger rivals? Stuart Freeman, the strategist who oversees Edwards' focus list, says the firm's St. Louis location probably helps: "We're les...Mon, 03 Aug 1998 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/1995/08/07/205147/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1995/08/07/205147/index.htmIt's a blood-borne disease, transmitted through transfusions, sex, and shared needles. And it's a silent disease; people can go years before developing any symptoms. Mon, 07 Aug 1995 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/1992/09/21/76897/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1992/09/21/76897/index.htmIt's been a rough ride for investors in growth stocks this year. While some of the best, like Wal-Mart Stores, Philip Morris, and Coca-Cola, are still within points of their highs, the rest have be...Mon, 21 Sep 1992 04:01:00 EDThttp://money.cnn.com/magazines/moneymag/moneymag_archive/1992/09/01/87505/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/1992/09/01/87505/index.htmWhen money managers recommend a stock, it's comforting to know that they own the shares themselves. But with the Dow at near-record heights and consumer confidence at a near-record low, I've been a...Tue, 01 Sep 1992 04:01:00 EDThttp://money.cnn.com/magazines/moneymag/moneymag_archive/1989/01/01/84921/index.htmhttp://money.cnn.com/magazines/moneymag/moneymag_archive/1989/01/01/84921/index.htmIn 1985, when the dollar began its downhill schuss against foreign currencies, falling nearly 50%, stocks in leading export companies moved sharply upward (see the chart below). Reason: as goods pr...Sun, 01 Jan 1989 05:01:00 ESThttp://money.cnn.com/magazines/fortune/fortune_archive/1985/10/28/66528/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1985/10/28/66528/index.htmThough they welcomed the general prospect of a weaker dollar with a brief cheer -- the Dow Jones industrial average rose more than 18 points the day after the Plaza Hotel announcement -- investors ...Mon, 28 Oct 1985 05:01:00 ESThttp://money.cnn.com/magazines/fortune/fortune_archive/1985/08/19/66326/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1985/08/19/66326/index.htmBIOTECHNOLOGY still generates more headlines than profits, and no major drug company knows that better than Schering-Plough. It made one of the earliest and costliest bets on the science -- and has...Mon, 19 Aug 1985 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/1985/08/19/66316/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1985/08/19/66316/index.htmCANCER is no longer a taboo subject at advertising agencies. Well before President Reagan's operation for cancer of the colon, Kellogg Co., the U.S. cereal king (1984 sales: $2.6 billion), launched...Mon, 19 Aug 1985 04:01:00 EDThttp://money.cnn.com/magazines/fortune/fortune_archive/1985/04/01/65767/index.htmhttp://money.cnn.com/magazines/fortune/fortune_archive/1985/04/01/65767/index.htmHoffman-La Roche said it was granted the first U.S. patent for a type of interferon that has been tested for treatment of cancer and as a prevention against the common cold. The New Jersey-based he...Mon, 01 Apr 1985 05:01:00 EST